Vicente Villanueva Selected Research

eslicarbazepine acetate

6/2021	Initial monotherapy with eslicarbazepine acetate for the management of adult patients with focal epilepsy in clinical practice: a meta-analysis of observational studies.
1/2021	Predictors of seizure freedom, response and retention after 12 months of treatment with eslicarbazepine acetate: A post-hoc analysis of the Euro-Esli study.
12/2020	Eslicarbazepine acetate in post-stroke epilepsy: Clinical practice evidence from Euro-Esli.
12/2019	Effectiveness and Safety/Tolerability of Eslicarbazepine Acetate in Epilepsy Patients Aged ≥ 60 Versus < 60 Years: A Subanalysis from the Euro-Esli Study.
7/2019	Eslicarbazepine acetate in epilepsy patients with psychiatric comorbidities and intellectual disability: Clinical practice findings from the Euro-Esli study.
1/2019	MONOZEB: Long-term observational study of eslicarbazepine acetate monotherapy.
12/2018	Dibenzazepine Agents in Epilepsy: How Does Eslicarbazepine Acetate Differ?
12/2017	Pooled efficacy and safety of eslicarbazepine acetate as add-on treatment in patients with focal-onset seizures: Data from four double-blind placebo-controlled pivotal phase III clinical studies.
11/2017	Euro-Esli: a European audit of real-world use of eslicarbazepine acetate as a treatment for partial-onset seizures.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vicente Villanueva Research Topics

Disease

26	Epilepsy (Aura) 04/2022 - 11/2007
25	Seizures (Absence Seizure) 10/2022 - 11/2007
6	Partial Epilepsies (Epilepsy, Partial) 06/2021 - 10/2012
4	Temporal Lobe Epilepsy 01/2021 - 06/2008
4	Dizziness (Lightheadedness) 01/2020 - 03/2012
4	Sleepiness 01/2020 - 01/2016
3	Lennox Gastaut Syndrome 10/2022 - 05/2018
3	Myoclonic Epilepsies (Myoclonic Encephalopathy) 10/2022 - 01/2021
3	Tuberous Sclerosis (Bourneville's Disease) 12/2021 - 01/2019
3	Drug Resistant Epilepsy 04/2019 - 01/2017
2	Generalized Epilepsy 01/2021 - 03/2009
2	Absence Epilepsy (Childhood Absence Epilepsy) 01/2021 - 01/2018
2	Headache (Headaches) 01/2020 - 01/2016
2	Neoplasms (Cancer) 01/2019 - 12/2016
2	Idiopathic Generalized Epilepsy 01/2018 - 03/2009
2	Status Epilepticus (Complex Partial Status Epilepticus) 07/2014 - 01/2011
1	Constipation 10/2022
1	Lethargy 10/2022
1	Hamartoma 12/2021
1	Progressive Myoclonic Epilepsies (Progressive Myoclonic Epilepsy) 01/2021
1	Infantile Spasms (West Syndrome) 01/2021
1	Autoimmune Diseases of the Nervous System 01/2021
1	Stroke (Strokes) 12/2020
1	Nasopharyngitis 01/2020
1	Intellectual Disability (Idiocy) 07/2019
1	Hyponatremia 01/2019
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2019
1	Memory Disorders (Memory Loss) 01/2019
1	Diarrhea 05/2018
1	Brain Diseases (Brain Disorder) 05/2018
1	Body Weight (Weight, Body) 05/2018
1	Epileptic Syndromes 01/2018
1	Juvenile Myoclonic Epilepsy 01/2018
1	Hippocampal Sclerosis 01/2017
1	Brain Neoplasms (Brain Tumor) 12/2016
1	Low Back Pain (Lumbago) 05/2010
1	Pain (Aches) 05/2010
1	Myofascial Pain Syndromes (Myofascial Pain Syndrome) 05/2010
1	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 11/2008
1	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 11/2008
1	Lafora Disease 04/2006
1	Chorea (Rheumatic Chorea) 11/2003

Drug/Important Bio-Agent (IBA)

13	Anticonvulsants (Antiepileptic Drugs)IBA 12/2020 - 11/2007
9	perampanelIBA 08/2022 - 01/2016
9	eslicarbazepine acetateIBA 06/2021 - 11/2017
8	Pharmaceutical PreparationsIBA 11/2021 - 03/2013
5	Lacosamide FDA Link 12/2016 - 03/2012
4	Levetiracetam (Keppra)FDA LinkGeneric 01/2021 - 01/2011
3	trans-sodium crocetinate (crocetin)IBA 12/2021 - 01/2019
3	CannabidiolIBA 01/2021 - 05/2018
2	Lamotrigine (Lamictal)FDA LinkGeneric 01/2021 - 01/2021
2	brivaracetamIBA 01/2021 - 04/2019
2	Sodium Channel BlockersIBA 02/2015 - 03/2012
2	Zonisamide (Zonegran)FDA LinkGeneric 04/2013 - 03/2009
1	soticlestatIBA 10/2022
1	CenobamateIBA 06/2022
1	Amobarbital (Amsal)IBA 11/2021
1	Everolimus FDA Link 01/2021
1	Topiramate (Topamax)FDA LinkGeneric 01/2021
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2021
1	phenyl-2-aminoethyl sulfide (PAES)IBA 04/2019
1	SodiumIBA 01/2019
1	Hormones (Hormone)IBA 01/2019
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2019
1	TOR Serine-Threonine KinasesIBA 01/2019
1	dibenzazepineIBA 12/2018
1	SolutionsIBA 05/2018
1	Immunoglobulin E (IgE)IBA 01/2018
1	AntibodiesIBA 01/2017
1	AMPA Receptors (AMPA Receptor)IBA 01/2016
1	AcidsIBA 01/2016
1	BenzodiazepinesIBA 01/2011
1	Phenytoin (Dilantin)FDA LinkGeneric 01/2011
1	Botulinum Toxins (Botulinum Toxin)IBA 05/2010
1	Protons (Proton)IBA 04/2006
1	Carbamazepine (Tegretol)FDA LinkGeneric 11/2003

Therapy/Procedure

9	Therapeutics 10/2022 - 04/2013
1	Complementary Therapies (Alternative Medicine) 01/2021
1	Electrodes (Electrode) 01/2018
1	Radiofrequency Ablation 01/2017
1	Operative Surgical Procedures 01/2017
1	Radiotherapy 11/2008
1	Drug Therapy (Chemotherapy) 11/2008
1	Anterior Temporal Lobectomy 06/2008